Boston Scientific Corp.

Coronavirus fears that have rocked the American stock market have not spared public companies based in Central Massachusetts. The area's 10 largest public companies lost an average of 14% in share price through Monday since the market peaked Feb. 19.

Central Massachusetts businesses with broad geographic reaches are feeling the effects of the spread of coronavirus.

Boston Scientific has won regulatory clearance for what it says is the first disposable duodenoscope, a device inserted through the mouth so doctors can look into the small intestine.

When Central Massachusetts companies look to fill software, programming or research jobs, they’re increasingly looking to foreign labor under an immigrant work program called H-1B.

Marlborough medical device giant Boston Scientific’s stocks rose 6% Wednesday morning after the company reported a $126-million profit on $2.7 billion in sales for the third quarter, exceeding the company’s guidance range for sales.

Marlborough medical company Boston Scientific announced Tuesday that Michael Jaff will join the company as the vice president for clinical affairs, innovation and technology, peripheral interventions by January 2020.

The U.S. Food and Drug Administration has approved Boston Scientific’s new imaging tool to be used with a deep brain stimulation device. 

Boston Scientific has closed on its $4-billion acquisition of U.K.-based cancer firm BTG nearly two weeks after U.S. trade regulators signed off on the deal. 

Marlborough biomanufacturing firm Boston Scientific is selling its drug-loadable microsphere business to a California biotech firm for $90 million.

Boston Scientific has closed on the $465-million acquisition of a California biotech about a month after announcing the deal that bolster’s the Marlborough medical device giant’s pain management offerings.